Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
%) doctoral scholarship holder in the field of bio-electrochemistry. The overall goal of this PhD is the development of novel aptamer-based electrochemical biosensing strategies that will pave the way
-
talented PhD students to develop and benchmark cutting-edge super-resolution imaging technologies. The project aims to establish a comprehensive approach for ultra-high-content, multimodal imaging
-
-regulatory network analysis approaches, developed and employed in the Malysheva Lab, are required to reveal these mechanisms. With the proposed project we aim to bridge this gap in our knowledge of cis
-
, biochemistry, genomics, bacterial genetics and bioinformatics. You can work both independently as well as in an international team You can plan and perform laboratory experiments accurately You have strong
-
campuses, benefits, strategic goals and your future colleagues. Would you like more information about EUTOPIA? Go to eutopia-university.eu , and read more about the role of the VUB in the development
-
. It is one of the largest, most exciting employers in the area and offers great career opportunities. With its 11 faculties and more than 85 departments offering state-of-the-art study programmes
-
. You will work on the cutting edge of both wind energy and machine learning, two of the fastest growing scientific disciplines, to develop machine learning surrogates of wind energy systems. As newer
-
Learning Agreement is completely filled in and signed, dated and stamped where necessary! Language skills Your knowledge of Dutch and English. Please consult the language requirements in order to prepare the
-
for doctoral scholarship holders on the pay scales for Contract Research Staff . Opportunities of career development (doctoral training) A stimulating and international research environment You will receive
-
/immunotherapies are insufficient due to resistance development and limited efficacy. Personalized medicine, focusing on novel prognostic and predictive biomarkers to identify patients that will respond to treatment